Showing 73–84 of 114 results

SITAPHAGE 50/500MG

451.00
<h6>By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

VALIANT 50MG TAB

550.00
<h6>This medicine is indicated in type 2 diabetes (a disorder characterized by high sugar levels in blood), in combination with

VALIANT M 50/1000MG TAB

424.00
<h6>Used to treat diabetes type 2.</h6>

VALIANT M 50/850MG TAB

383.00
<h6 class=""MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3"">Used For  Diabetes</h6>

VELON M TAB 50/500MG

833.00
<h6>Vildagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of

VELON M 50/1000MG TAB

233.00
<h6 class=""MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3"">Used For  Diabetes</h6>

VELON M 50/850MG TAB

233.00
<h6>Vildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin

VIGLIP 50MG TAB

990.00
<h6>This medicine is indicated in type 2 diabetes (a disorder characterized by high sugar levels in blood), in combination with

VIGLIP M 50/1000 TAB

495.00
<h6>This medicine is indicated in type 2 diabetes (a disorder characterized by high sugar levels in blood), in combination with

VIGLIP M 50/500 TAB

495.00
<h6>This medicine is indicated in maturity onset diabetes either alone or with sulphonylureas. It is also used as adjuvant therapy

VIGLIP M 50/850 TAB

495.00
<h6>This medicine is indicated in type 2 diabetes (a disorder characterized by high sugar levels in blood), in combination with

VILDA PLUS 50/850MG TAB

445.00
<h6>For the treatment of type 2 diabetes mellitus in adults As monotherapy in patients inadequately controlled by diet and exercise